(Q41410223)

30 September 2017

1 reference

title

Can we predict aggressive disease? (English)

1 reference

30 September 2017

Young A

1

1 reference

PubMed ID

9088523

30 September 2017

van der Heijde DM

series ordinal

2

1 reference

30 September 2017

1 February 1997

1 reference

Bailliere's clinical rheumatology

30 September 2017

1 reference

30 September 2017

11

1 reference

30 September 2017

1

1 reference

30 September 2017

27-48

1 reference

Are both genetic and reproductive associations with rheumatoid arthritis linked to prolactin?

30 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Factors predicting death, survival and functional outcome in a prospective study of early rheumatoid disease over fifteen years

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Work disability in early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Early rheumatoid arthritis--onset, course, and outcome over 2 years

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Genetically determined factors as predictors of radiological change in patients with early symmetrical arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Prognosis in rheumatoid arthritis. A longitudinal study of newly diagnosed younger adult patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Importance of sensitivity to change as a criterion for selecting health status measures

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Prognostic value of early features in rheumatoid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Rheumatoid factor, chronic arthritis and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Predicting the outcome of rheumatoid arthritis. A Soviet-Finnish co-operative study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Onset, early stages, and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Does exposure to immunosuppressive therapy increase the 10 year malignancy and mortality risks in rheumatoid arthritis? A matched cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

IgM, IgA, and IgG rheumatoid factors in early rheumatoid arthritis predictive of radiological progression?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Predictors of disability in a longitudinal sample of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Analysis of serial measurements in medical research

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

The importance of age, education, and comorbidity in the substantial earnings losses of individuals with symmetric polyarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Prognostic markers of activity and damage in rheumatoid arthritis: why clinical trials and inception cohort studies indicate more favourable outcomes than studies of patients with established disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Cause and age at death in a prospective study of 100 patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

The natural history of rheumatoid arthritis: a fifteen year follow-up study. The prognostic significance of features noted in the first year

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Predictors of outcome at two years in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Mortality and survival in rheumatoid arthritis: a 25 year prospective study of 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Long-term outcome of treating rheumatoid arthritis: results after 20 years

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Therapeutic criteria in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Should patients with recent onset rheumatoid arthritis be offered genetic screening?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Prospective study of early rheumatoid arthritis. I. Prognostic value of IgA rheumatoid factor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Record linkage to conduct an epidemiologic study on the association of rheumatoid arthritis and lymphoma in the Province of Saskatchewan, Canada.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

A prospective study of early onset rheumatoid arthritis over fifteen years: prognostic features and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

A prognostic index for erosive changes in the hands, feet, and cervical spines in early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Agalactosyl IgG: an aid to differential diagnosis in early synovitis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2897%2980031-3

7 January 2021

10.1016/S0950-3579(97)80031-3

Identifiers

DOI

1 reference

release_cdqj2i3pqfejth46gz6vja7pea

30 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cdqj2i3pqfejth46gz6vja7pea

24 November 2022

mapped directly with Wikidata item

PubMed ID

9088523

1 reference

PubMed ID

9088523